Stanford researchers to assess favipiravir in Covid-19 outpatients
The drug has already secured approval for treating Covid-19 in Russia, China and India. Credit:
Jernej Furman.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more